Loading...
Thermodynamic investigation of carbamazepine-saccharin co-crystal polymorphs
Pagire, Sudhir K. Jadav, Niten B. Vangala, Venu R. Whiteside, Benjamin R.
Pagire, Sudhir K.
Jadav, Niten B.
Vangala, Venu R.
Whiteside, Benjamin R.
Publication Date
2017
End of Embargo
Supervisor
Rights
© 2017 The Authors. Published by Elsevier Inc. on behalf of the American
Pharmacists Association. This is an open access article available under the terms of the Creative
Commons Attribution License (CC BY 4.0).
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2017-04-10
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
Polymorphism in active pharmaceutical ingredients (APIs) can be regarded as critical for the potential that crystal form can have on the quality, efficacy and safety of the final drug product. The current contribution aims to characterize thermodynamic interrelationship of a dimorphic co-crystal, FI and FII, involving carbamazepine (CBZ) and saccharin (SAC) molecules. Supramolecular synthesis of CBZ-SAC FI and FII have been performed using thermo-kinetic methods and systematically characterized by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), solubility and slurry measurements. According to Berger and Ramberger’s heat of fusion rule, FI (ΔHfus = 121.1 J/g, mp 172.5 °C) and FII (ΔHfus= 110.3 J/g, mp 164.7 °C) are monotropically related. The solubility and van’t Hoff plot results suggest that FI stable and FII metastable forms. This study reveals that CBZ-SAC co-crystal phases, FI or FII, could be stable to heat induced stresses, however, FII converts to FI during solution mediated transformation.
Version
Published version
Citation
Pagire SK, Jadav N, Vangala VR et al (2017) Thermodynamic investigation of carbamazepine-saccharin co-crystal polymorphs. Journal of Pharmaceutical Sciences. 106(8): 2009-2014.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article